IMUC

ImmunoCellular Therapeutics, Ltd., based in Los Angeles, is developing immune-based therapies for the treatment of cancer.

[IMUC @ImmunoCellular]

ImmunoCellular Therapeutics Announces Delisting and Deregistration of Common Stock and Listed Common Stock Warrants https://t.co/e8C9s3w4mM $IMUC

[IMUC @ImmunoCellular]

ImmunoCellular Therapeutics Provides Corporate Update and Reports Second Quarter 2018 Financial Results https://t.co/nsYZt4c1eV $IMUC

[IMUC @ImmunoCellular]

ImmunoCellular Therapeutics Announces Agreement on Terms of Settlement of Federal Class Action Shareholder Lawsuit https://t.co/CfCtFVUNiw $IMUC

[IMUC @ImmunoCellular]

ImmunoCellular Therapeutics Announces First Quarter 2018 Financial Results https://t.co/ORQ6T6nZ1C $IMUC

[IMUC @ImmunoCellular]

ImmunoCellular Therapeutics Announces Achievement of Next Key Milestone in Stem-to-T-Cell Research Immuno-Oncology Program https://t.co/qLPqLKlOZ9 $IMUC

[IMUC @ImmunoCellular]

ImmunoCellular Therapeutics Announces Fourth Quarter and Full Year 2017 Financial Results https://t.co/lmwqkkZPeb $IMUC

[IMUC @ImmunoCellular]

ImmunoCellular Therapeutics to Report Fourth Quarter and Full Year 2017 Financial Results on March 13, 2018 https://t.co/GI3DFYTLnC $IMUC

[IMUC @ImmunoCellular]

ImmunoCellular Therapeutics Announces Review of Strategic Alternatives https://t.co/YCxxthpopk $IMUC

[IMUC @ImmunoCellular]

ImmunoCellular Therapeutics Announces Update on Financial Condition https://t.co/Ezy2ggUawF $IMUC

[IMUC @ImmunoCellular]

ImmunoCellular Therapeutics Achieves Key Milestone in Stem-to-T-Cell Research Immuno-Oncology Program https://t.co/rm8SkMFnI2 $IMUC

[IMUC @ImmunoCellular]

Next week Dec 7, 2017 ImmunoCellular Therapeutics to Present at LD Micro Main Event https://t.co/c9znlnEi4I $IMUC

[IMUC @ImmunoCellular]

ImmunoCellular Therapeutics to Present at the 10th Annual LD Micro Main Event on December 7, 2017 https://t.co/zSXm23kTRO $IMUC

[IMUC @ImmunoCellular]

Conference call and webcast 5pm EST today - 3Q Financial results and business update https://t.co/w9LeIkz35z $IMUC

[IMUC @ImmunoCellular]

ImmunoCellular Therapeutics Announces Third Quarter 2017 Financial Results. Conference call and webcast today https://t.co/ikRP875GrV $IMUC

[IMUC @ImmunoCellular]

ImmunoCellular Therapeutics to Report Third Quarter 2017 Financial Results on November 21, 2017 https://t.co/oZodhLM6Pq $IMUC

[IMUC @ImmunoCellular]

Today 2pm EDT ImmunoCellular to present at Lytham Partners Virtual Investor Conference. Webcast and info: https://t.co/CVpbAgt99M $IMUC

[IMUC @ImmunoCellular]

ImmunoCellular Therapeutics to Present at the Lytham Partners Virtual Investor Conference on October 11 https://t.co/pyxKacycF1 $IMUC

[IMUC @ImmunoCellular]

ImmunoCellular Therapeutics Announces NYSE MKT Acceptance of its Plan of Compliance https://t.co/XHEkFFZjmb $IMUC

[IMUC @ImmunoCellular]

Today 5pm EDT, ImmunoCellular Business Update on Research & Development & Future Strategy. Webcast: https://t.co/8wib7cXEC9 $IMUC

[IMUC @ImmunoCellular]

ImmunoCellular Therapeutics Provides Business Update on Research and Development Programs and Future Strategy https://t.co/6vEjFjNM46 $IMUC